{ }
Very Negative
Negative
Neutral
Positive
Very Positive
2025-04-052025-04-051111100
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-04-052025-04-051111100
Download SVG
Download PNG
Download CSV

ubs upgrades roche to preferred pharmaceutical stock with strong growth potential

UBS has named Roche as its preferred Swiss pharmaceutical stock, upgrading its rating to "Buy" and raising the target price from CHF 300 to CHF 338. The firm cites Roche's sustainable growth, driven by strong performances from Vabysmo and Ocrevus, and anticipates significant sales increases from ongoing development projects, including Ocrevus HD and Trontinemab. While Roche's earnings per share growth is projected at 8.1% from 2024 to 2029, slightly below the industry average, UBS remains optimistic about the company's long-term potential and cash flow for acquisitions.

Roche shares rise after UBS upgrades stock recommendation to buy

Roche shares surged 1.3% after UBS upgraded its recommendation from 'neutral' to 'buy', raising the price target from CHF 300 to CHF 338. The firm highlighted sustainable growth driven by key products like Vabysmo and Ocrevus, with potential for an additional $16 billion in sales from products in development.

spi index declines as market sentiment shifts in zurich

The SPI index in Zurich closed 0.28% lower at 16,709.95 points, with a market capitalization of EUR 2.240 trillion. Over the past year, the index has risen 7.68%, reaching a high of 16,867.77 points, while Highlight Event and Entertainment led gains with a 23.75% increase. Conversely, Leonteq saw the largest decline at -7.57%.

spi index rises 0.13 percent with notable stock performances in zurich

The SPI rose by 0.13% to 16,778.78 points on Friday, marking a weekly gain of 1.56% and an 8.12% increase since the start of 2025. Highlight Event and Entertainment led the gains with a 25% rise, while Leonteq saw the largest decline at -7.57%. UBS had the highest trading volume, and Roche maintained the largest market capitalization at €258.575 billion.

Swiss stock market dips as labor data and tech sector woes weigh down indices

The Swiss stock market experienced a slight decline, with the SMI closing 0.24% lower at 12,593.34 points, marking its first loss after six weeks of gains. Swisscom and Holcim saw gains amid merger rumors, while financial stocks like Julius Baer and Partners Group faced significant losses. The US labor market data influenced investor sentiment, with employment growth slightly below expectations but a drop in the unemployment rate to 4%.

Swiss stock market gains momentum led by UBS and Holcim shares

Swiss equities showed slight gains, with the SMI rising 0.4% to 12,624 points, supported by strong performances from Holcim (+3.7%) and UBS (+3.6%). Optimism among Swiss entrepreneurs and a positive impulse from the Bank of England contributed to the market's mood, despite losses in major pharmaceutical stocks Roche (-1.2%) and Novartis (-0.9%).

Swiss stock market maintains upward trend amid trade war concerns

The Swiss stock market maintained its upward momentum at midday, with the SMI up 0.44% as concerns over the US-China trade conflict lingered. UBS led gains at +1.9%, while Temenos rose 1.4% after selling its fund management unit. However, Leonteq faced an 8.4% drop following regulatory sanctions.

Swiss stock market opens higher amid improving US and European sentiment

The Swiss stock market opened higher on Thursday, continuing its positive trend from the previous day, buoyed by favorable US data and easing trade tensions. The SMI rose 0.19% to 12,604.86 points, with UBS leading gains at +1.6%, while Nestlé and Roche weighed on the indices. The unemployment rate in Switzerland surpassed 3% in January, reflecting a 20% increase compared to the previous year.

Zurich SPI Index Shows Gains with Notable Stock Performances

The SPI index in Zurich opened 0.17% higher at 16,713.26 points, with a market capitalization of €2.226 trillion. Year-to-date, the SPI has gained 7.70%, reaching a high of 16,867.77 points, while UBS leads in trading volume. Highlight Event and Entertainment saw the largest gain at +14.29%, while ASMALLWORLD faced the steepest decline at -6.43%.

swiss equities decline as UBS shares slump amid financial market uncertainty

Swiss equities faced a downturn, with the SMI index dropping 0.57% to 12,475.49 points, primarily due to a 7.1% decline in UBS shares amid capital concerns despite positive results. The market remains volatile, influenced by ongoing tariff disputes, particularly with China. Notable losers included Swatch (-3.2%) and Sonova (-3.4%), while Medacta stood out with an 11% gain following strong sales figures.

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.